Winfield Associates’s Exelixis EXEL Stock Holding History

Winfield Associates’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-300	Closed	-$10K	–	297
2017 Q4	$10K	Hold	300	–	–	0.01%	419
2017 Q3	$7K	Hold	300	–	–	﹤0.01%	449
2017 Q2	$7K	Hold	300	–	–	﹤0.01%	453
2017 Q1	$7K	Hold	300	–	–	﹤0.01%	428
2016 Q4	$4K	Hold	300	–	–	﹤0.01%	460
2016 Q3	$4K	Hold	300	–	–	﹤0.01%	425
2016 Q2	$2K	Hold	300	–	–	﹤0.01%	527
2016 Q1	$1K	Hold	300	–	–	﹤0.01%	579
2015 Q4	$2K	Hold	300	–	–	﹤0.01%	288
2015 Q3	$2K	Hold	300	–	–	﹤0.01%	287
2015 Q2	$1K	Hold	300	–	–	﹤0.01%	281
2015 Q1	$1K	Hold	300	–	–	﹤0.01%	286
2014 Q4	$0	Hold	300	–	–	﹤0.01%	301
2014 Q3	$0	Hold	300	–	–	﹤0.01%	296
2014 Q2	$1K	Hold	300	–	–	﹤0.01%	299
2014 Q1	$1K	Hold	300	–	–	﹤0.01%	285
2013 Q4	$2K	Buy	+300	New	+$1.65K	﹤0.01%	273

Other funds holding EXEL

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Winfield Associates's EXEL Position: Q1 2018 in Review

Winfield Associates sold out of Exelixis (EXEL) in Q1 2018, closing a stake of 300 shares — an estimated $10K sold.

Winfield Associates first reported a position in EXEL in Q4 2013 and held it in 17 quarters. The position peaked at $10K in Q4 2017. 294 funds tracked by Wall St. Rank hold EXEL as of Q1 2018.

Winfield Associates reported no remaining Exelixis position as of Q1 2018 after selling out during the quarter.
Winfield Associates sold 300 Exelixis shares in Q1 2018, an estimated $10K.
Winfield Associates first reported a position in Exelixis in Q4 2013 and held it in 17 quarters.
Winfield Associates's Exelixis position peaked at $10K in Q4 2017.
294 funds tracked by Wall St. Rank held Exelixis as of Q1 2018.

Based on Winfield Associates's 13F filing for Q1 2018, filed 10 May 2018.